Viatris Inc (VTRS) stock
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/303% below fair value
$19.88−0.40 (-1.97%)
Close on Nov 19, 2026Market cap $22.83BP/E –Yield 2.41%
Viatris shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Viatris's shares outstanding was 1.16B at Jun 30, 2026. For fiscal 2023 it was 1.21B, down 0.9% from the year before. The highest annual figure on record is 1.22B in fiscal 2022.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 1.21B | -0.9% |
| FY2022 | Dec 31, 2022 | 1.22B | +0.7% |
| FY2021 | Dec 31, 2021 | 1.21B | +101.1% |
| FY2020 | Dec 31, 2020 | 601M | +16.4% |
| FY2019 | Dec 31, 2019 | 517M | 0.0% |
| FY2018 | Dec 31, 2018 | 517M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1.16B | -2.4% |
| Q1 FY2026 | Mar 31, 2026 | 1.18B | -2.1% |
| Q3 FY2025 | Sep 30, 2025 | 1.16B | -2.2% |
| Q2 FY2025 | Jun 30, 2025 | 1.17B | -3.0% |
| Q1 FY2025 | Mar 31, 2025 | 1.19B | -1.5% |
| Q3 FY2024 | Sep 30, 2024 | 1.20B | -0.6% |
| Q2 FY2024 | Jun 30, 2024 | 1.19B | -1.0% |
| Q1 FY2024 | Mar 31, 2024 | 1.21B | +0.3% |
| Q4 FY2023 | Dec 31, 2023 | 1.21B | -0.9% |
| Q3 FY2023 | Sep 30, 2023 | 1.21B | -0.9% |
| Q2 FY2023 | Jun 30, 2023 | 1.20B | -1.1% |
| Q1 FY2023 | Mar 31, 2023 | 1.21B | -0.6% |
| Q4 FY2022 | Dec 31, 2022 | 1.22B | +1.0% |
| Q3 FY2022 | Sep 30, 2022 | 1.22B | +0.5% |
| Q2 FY2022 | Jun 30, 2022 | 1.22B | +0.7% |
| Q1 FY2022 | Mar 31, 2022 | 1.21B | +0.5% |
| Q4 FY2021 | Dec 31, 2021 | 1.21B | +41.8% |
| Q3 FY2021 | Sep 30, 2021 | 1.21B | +134.2% |
| Q2 FY2021 | Jun 30, 2021 | 1.21B | +133.7% |
| Q1 FY2021 | Mar 31, 2021 | 1.21B | +133.6% |
| Q4 FY2020 | Dec 31, 2020 | 853M | +852899900.0% |
| Q3 FY2020 | Sep 30, 2020 | 518M | +517699900.0% |
| Q2 FY2020 | Jun 30, 2020 | 517M | – |
| Q1 FY2020 | Mar 31, 2020 | 517M | – |
| Q3 FY2019 | Sep 29, 2019 | 0M | – |
| Q2 FY2019 | Jun 30, 2019 | 0M | – |
See a number that looks wrong?